HUTCHMED Ltd. Financials

Market Capitalization £1.94 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	3288.89
Forward PE	75.33
Price to Sales TTM	£3.18
Price to Book MRQ	£260.97
Enterprise to Revenue	2.11
Enterprise to EBITDA	-11.69

Financial Reports as of Jun. 30, 2021

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2021-06-30
Profit Margin	-6.87%
Operating Margin	-9.00%
Return on Assets TTM	-5.90%
Return on Equity TTM	-5.44%

Income Statement

Revenue TTM	£498,466,555
Revenue per Share TTM	£0.72
Quarterly Revenue Growth	-42.60%
Gross Profit TTM	£-38,725,442
EBITDA	£67,274,000
Net Income to Common TTM	£-34,250,876
Diluted EPS TTM	£-0.04
Quarterly Earnings Growth YoY	-84.70%

Balance Sheet

Total Cash MRQ	£655,728,429
Total Cash per Share MRQ	£0.94
Total Debt MRQ	£
Total Debt to Equity MRQ	11.78
Current Ratio MRQ	2.81
Book Value per Share MRQ	£0.87

Cash Flow

Operating Cash Flow TTM	£-38,336,988
Levered Free Cash Flow TTM	£-48,319,585

HCM Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	854,681,024
Float Shares	515,876,723
Avg 10 Volume	44,684
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	38.94%
% Held by Institutions	28.95%

Stock Price Summary

Beta	0.75
Fifty Two Week Low	£190.40
Fifty Two Week High	£353.00
Fifty Two Week Change	6.16%
Day 50 MA	£256.82
Day 200 MA	£281.67

Dividends and Splits

Forward Annual Dividend Rate	£
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	£0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2019-05-30